Charles D Logan, Matthew T Hudnall, Cary Jo R Schlick, Dustin D French, Brian Bartle, Dominic Vitello, Hiten D Patel, Lauren M Woldanski, Daniel E Abbott, Ryan P Merkow, David D Odell, David J Bentrem
IMPORTANCE: Venous thromboembolism (VTE) represents a major source of preventable morbidity and mortality and is a leading cause of death in the US after cancer surgery. Previous research demonstrated variability in VTE chemoprophylaxis prescribing, although it is unknown how these rates compare with performance in the Veterans Health Administration (VHA). OBJECTIVE: To determine VTE rates after cancer surgery, as well as rates of inpatient and outpatient (posthospital discharge) chemoprophylaxis adherence within the VHA...
September 5, 2023: JAMA Network Open